What are the epileptic encephalopathies?

Marina Trivisano1, Nicola Specchio

  • 1Rare and Complex Epilepsy Unit, Department of Neuroscience, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Insights

The concept of epileptic encephalopathy has evolved, with the International League Against Epilepsy classifying developmental and epileptic encephalopathies (DEE). Early DEE cause identification may enable targeted treatments for cognitive and seizure improvements.

Area of Science:

  • Neurology
  • Developmental Neuroscience
  • Epilepsy Research

Background:

  • Developmental delay in children with epilepsy can stem from its cause, epileptiform activity, or both.
  • The International League Against Epilepsy (ILAE) classification now includes developmental and epileptic encephalopathy (DEE).

Purpose of the Study:

  • To review the historical evolution of the epileptic encephalopathy concept.
  • To analyze the impact of the current DEE definition on clinical practice and research.

Main Methods:

  • Review of the evolution of epileptic encephalopathy concepts.
  • Analysis of the ILAE classification of DEE.
  • Exploration of potential DEE pathogenetic mechanisms.

Main Results:

  • DEE encompasses conditions where developmental delay, epilepsy, and encephalopathy coexist.
  • Potential DEE pathogenesis involves pathways like DNA repair, transcriptional regulation, and myelination.
  • Epilepsy and epileptiform discharges may impact cognition through various, not fully understood, mechanisms.

Conclusions:

  • Accurate and early DEE cause identification is crucial for targeted treatment strategies.
  • Intervening in DEE's neurobiological processes offers the best approach to improve cognitive deficits and epilepsy.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
811
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
545
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.5K